Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.

@article{Baur2011Type2D,
  title={Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.},
  author={Dorothee Maria Baur and Jens Klotsche and Ole-Petter Riksfjord Hamnvik and Caroline Sievers and Lars Pieper and Hans-Ulrich Wittchen and Guenter Karl Stalla and Roland M Schmid and Stefanos N. Kales and Christos Socrates Mantzoros},
  journal={Metabolism: clinical and experimental},
  year={2011},
  volume={60 10},
  pages={1363-71}
}
There is growing evidence that patients with type 2 diabetes mellitus have increased cancer risk. We examined the association between diabetes, cancer, and cancer-related mortality and hypothesized that insulin sensitizers lower cancer-related mortality. Participants in the Diabetes Cardiovascular Risk and Evaluation: Targets and Essential Data for Commitment of Treatment study, a nationwide cross-sectional and prospective epidemiological study, were recruited from German primary care practices… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 38 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 21 references

Cardiovascular risk factors in primary care: methods and baseline prevalence rates–the DETECT program

  • HU Wittchen
  • Curr Med Res Opin 2005;21:619-30
  • 2005
Highly Influential
4 Excerpts

Similar Papers

Loading similar papers…